I think GLYC is due for a pullback. What are your thoughts? have you guys heard of awe-some*sto-cks. i started receiving their allerts and so far i am happy.
What's going on?
What is going on here. Durign the day, the price drops to low 11, an after hours it goes 1 dollar up. and it's another day in a row
GLYC, looks to be overvalued at this price google awesome_stock.s - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading.
Interesting. . . I posted a link related to GLYC's development and lead candidate earlier, but it seems to have been deleted. Surely no censorship on an open message board!
I'll post it again, no biggie. My legitimate question for this board is as follows: Does Midostaurin pose a threat to GLYC's GMI-1271? Here is a link to the story. . . and I hope "yahoo" does not strike down a legitimate and possibly serious concern for traders and investors on this board. If someone can give me an educated answer. I will let it go, but keep posting it otherwise.
Invest in Buying Collective Holdings Inc. | Organic, non-GMO foods at wholesale prices, delivered to your doorstep on @wefunder
We're focused on (1) building the Buying Collective of CLEAN food shoppers through the Health Merchant® network; (2) sourcing CLEAN foods at the lowest possible cost; and (3) selling CLEAN foods with direct, free delivery to households that are part
Did I read this report wrong? why is this thing getting hammered today? I thought update was good news??
$25 per share! Easy buy-out for GILD or Amgen!
strong pipeline drugs! The earning per share will sharply rise soon!
wow $16 up!!!!!
CEO and Co-Founder Rachel K. King recently did a long interview, worth a look.
“We have basically taken the technology around how to rationally design what we call glycomimetic molecules and now have applied that to several diseases in the hematology space.”
Interview with the Co-Founder and CEO: GlycoMimetics, Inc. (NASDAQ:GLYC) - The Wall Street Transcript
TWST: Can you briefly describe what the company is and describe its core technology? Mrs. King: The core technology enables us to target carbohydrate-related mechanisms of disease with small molecules, and we have applied that to several disease targ
The upside potential for GLYC just got a whole lot more interesting. Im not sure about you guys but awe.some.stock.s has provided me with some pretty good trade ideas. I messed up executing some of them but thats on me.
Buy on RUMOR....Sell on FAKE NEWS!. No volume - big boys are gone. Wait for next new round of funding with millions of more shares just to keep afloat.